With the development of biological tissue engineering, vascular stent materials have been greatly improved. Synthetic polyester polymers and bio-derived materials with excellent biocompatibility, biodegradability and mechanical strength have greatly improved. These are ideal tissue vascular scaffold materials. Vascular stents mainly play two roles in the body: vascular regeneration and prevention of vascular restenosis. In terms of vascular regeneration, the repair of common bone defects and the pulp regeneration require revascularization. This type of stent has production-promoting ability of adopting the multi-level microtubule structure. Different aperture induces different vascular behavior of making the adhered macrophages deforming correspondingly, promoting the infiltration of endothelial cells into the extracellular matrix and accelerating the formation of new blood vessels. In the treatment of atherosclerosis, stents can not only support blood vessels, but also prevent blood vessel from restenosis and keep blood vessels opening for a long time. To this aim, stents generally carry and controllable release of drugs of inhibiting the proliferation of smooth muscle cells. Such stents are called drug-eluting stents. Usual drugs are rapamycin and paclitaxel. This review intends to mix the nano-scale anticancer drug nanoenzymes with polymers on the surface of the stent and exert the sustained drug releasing function of the drug-eluting stent. This type of drug-eluting stent can not only prevent blood vessel restenosis, but also treat cancer by attacking tumor cells.
| Published in | International Journal of Materials Science and Applications (Volume 10, Issue 2) |
| DOI | 10.11648/j.ijmsa.20211002.13 |
| Page(s) | 35-45 |
| Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
| Copyright |
Copyright © The Author(s), 2021. Published by Science Publishing Group |
Angiogenesis, Vascular Restenosis, Multi-level Microtubule Structure, Drug-eluting Stent, Nanoenzyme
| [1] | Yang Lei, Li Xiafei, et al. Small-caliber tissue engineering vascular scaffold: how to produce a material with physiological remodeling activity [J], Chinese Tissue Engineering Research, 2019. |
| [2] | Ye Haimin, Ding Linghua, Kong Wei, et al., Multi-level microtubule structure bone scaffold carrier promotes osteogenesis and angiogenesis and its mechanism [J]. |
| [3] | Huang Shupei, Liang Yuanfeng, Hao Junhai, et al. The effect of heparin grafting on the structure and anticoagulant effect of vascular acellular scaffolds [J], Guangdong Medicine, May 2019, Vol. 40, No. 10. |
| [4] | Liu Yi, Zhou Qingzhu, Gong Zhuo, et al. The characteristics and manufacturing technology of collagen/inorganic materials to construct tissue engineering bone [J]. |
| [5] | DONG C, LVY. Application of collagen scaffold in tissue engineering: recent advances and new perspectives. Polymers (Basel).2016; 8 (2): 42-62. |
| [6] | KANG L, JIA W, LI M, et al. Hyaluronic acid oligosaccharide-modified collagen nanofibers as vascular tissue-engineered scaffold for promoting endothelial cell proliferation. Carbohydr Polym. 2019; 2 (23): 106-115. |
| [7] | ZHOU J, YING H, WANG M, et al. Dual layer collagen-GAG conduit that mimic vascular scaffold and promote blood vessel cells adhesion, proliferation and elongation. Mater sci Eng C Mater Biol Appl. 2018; 92: 447-452. |
| [8] | BADHE RV, BIJUKUMAR D, CHEJARA DR, et al. A composite chitosan-gelatin bi-layered, biomimetic microporous scaffold for blood vessel tissue engineering. Carbohydr Polym. 2017; 157: 1215-1225. |
| [9] | REZ MFA, BINOBAID A, ALGHOSEN A, et al. Tubular Poly/Chitosan Nanofibrous Scaffold Prepared by Electrospinning for Vascular Tissue Engineering Applications. J Bioma Tissue Eng. 2017; 7 (6): 427-436. |
| [10] | PANKAJAKSHAN D, PHILIPOSE LP, PALAKKAL M, et al. Develpment of a fibrin composite-coated poly scaffold for potential vascular tissue engineering applications. J Biomed Mater Res B Appl Biomater. 2010; 87B (2): 570-579. |
| [11] | Chen Leyi, Lu Xiaolin, Xu Wenan, Application of scaffold materials in pulp regeneration and revascularization [J], Chinese Tissue Engineering Research. |
| [12] | KESWANI D, PANDEY RK. RevascuIarization of an immature tooth with a necrotic puIp using pIateIet-rich fibrin: a case report. Int Endod J. 2013; 46 (11): 1096-1104. |
| [13] | Wu Xiaotong, He Er, Liu Laijun, et al. Research progress of tissue engineering scaffolds based on polycaprolactone fibers [J], Chinese Journal of Biomedical Engineering, October 2020, Volume 39, Issue 5. |
| [14] | Chen Dairui, Bei Jianzhong. Wang Sheng guo. Polycaprolactone microparticles and their biodegradation [J]. Polym Degrad Stab, 2000, 67 (3): 455-459. |
| [15] | Garkhal K, Verma S, Jonnalagadda S, et al. Fast degradable poly microspheres for tissue engineering: Synthesis, characterization, and degradation behavior [J]. J Polym Sci Pol Cem, 2007, 45 (13): 2755-2764. |
| [16] | ABUDULA T, SAEED U, MEMIC A, et al. Electrospun PHEA-PLA/PCL Scaffold for Vascular Regeneration: A Preliminary in Vivo Evaluation, Transplantation Proceedings 2017; 49 (4): 716-721. |
| [17] | Chen Ming, Peng Hongyu, Huo Yong, etc., a new type of biodegradable polymer coating. Effect of rapamycin-eluting stent on neointimal hyperplasia of porcine coronary arteries [J], Journal of Cardiopulmonary and Vascular Disease, Vol. 29, Issue 4, July 2010. |
| [18] | Commandeur S, Van Beusekom H M, Van Der Giessen, W J. Polymers, drug release and drug-eluting stents. J Interv Cardiol. 2006, 19: 500-506. |
| [19] | Zhou C, Li H F, Yin Y X, et al. Long-term in vivo study of biodegradable Zn-Cu stent: A 2-year implantation evaluation in porcinecoronary artery [J]. Acta Biomater., 2019, 97: 657. |
| [20] | MENG Y, LIU L J, ZHANG D W, et al. Initial formation of corrosion products on pure zinc in saline solution [J], Bioactive Materials, 2019, 4 (1): 87-96. |
| [21] | WEISS J H, SENSI S L, KOH J Y. Zn(II): a novel ionic mediator of neural injury in brain disease [J], Trends in Pharmacological Sciences, 2000, 21 (10): 395-401. |
| [22] | Liu Lijun, Study on the corrosion behavior and mechanical behavior of pure zinc in simulated body fluids [J], University of Science and Technology Beijing. |
| [23] | Qian Yi, Yuan Guangyin, Research status, challenges and countermeasures of biodegradable zinc alloy vascular stents [J], Acta Metallurgica Sinica, March 2021, Vol. 57 No. 3. |
| [24] | Capasso D, Di Gaetano S, Celentano V, et al. Unveiling a VEGF-mimetic peptide sequence in the IQGAP1 protein [J]. Mol Biosyst, 2017, 13 (8): 1619-1629. DOI: 10.1039/c7mb00190h. Yang Y, Yang Q, Zhou F, et al. Electrospun PELCL membranes loaded with QK peptide for enhancement of vascular endothelial cell growth [J]. J Mater Sci Mater Med, 2016, 27 (6): 106. DOI: 10.1007/s10856-016-5705-6. |
| [25] | Yang Y, Yang Q, Zhou F, et al. Electrospun PELCL membranes loaded with QK peptide for enhancement of vascular endothelial cell growth [J]. J Mater Sci Mater Med, 2016, 27 (6): 106. DOI: 10.1007/s10856-016-5705-6. |
| [26] | Seo E, Lim JS, Jun JB, et al. Exendin-4 in combination with adipose-derived stem cells promotes angiogenesis and improves diabetic wound healing [J]. J Transl Med, 2017, 15 (1): 35. DOI: 10.1186/s12967-017-1145-4. |
| [27] | Kang HM, Sohn I, Jung J, et al. Exendin-4 protects hindlimb ischemic injury by inducing angiogenesis [J]. Biochem Biophys Res Commun, 2015, 465 (4): 758-763. DOI: 10.1016/j.bbrc.2015.08.080. |
| [28] | Adini A, Adini I, Chi ZL, et al. A novel strategy to enhance angiogenesis in vivo using the small VEGF-binding peptide PR1P [J]. Angiogenesis, 2017, 20 (3): 399-408. DOI: 10.1007/s10456-017-9556-7. |
| [29] | Chen Tianhong, Li Jingfeng, Research progress of small molecule active peptides in bone tissue engineering [J], International Journal of Biomedical Engineering, Vol. 43 No. 5, October 2020. |
| [30] | Jonkheijm P. Guiding hMSC adhesion and differentiation on supported lipid bilayers [J]. Adv Healthc Mater, 2017, 6 (3): 201600862. DOI: 10.1002/adhm.201600862. |
| [31] | Mehta M, Madl CM, Lee S, et al. The collagen I mimetic peptide DGEA enhances an osteogenic phenotype in mesenchymal stem cells when presented from cell-encapsulating hydrogels [J]. J Biomed Mater Res A, 2015, 103 (11): 3516-3525. DOI: 10.1002/jbm.a.35497. |
| [32] | Ravanetti F, Gazza F, D'arrigo D, et al. Enhancement of peri-implant bone osteogenic activity induced by a peptidomimetic functionalization of Titanium [J]. Ann Anat, 2018, 218 (218): 165-174. DOI: 10.1016/j.aanat.2018.01.011. |
| [33] | BALDWINP, LIDJ, AUSTONDA, et al. Autograft, Allograft, and Bone Graft Substitutes: Clinical Evidence and Indications for Use in the Setting of Orthopaedic Trauma Surgery. J Orthop Trauma. 2019; 33 (4): 203-213. |
| [34] | GRIGORIAN SHAMAGIAN L, MADONNA R, TAYLORD, et al. Perspectives on Directions and Priorities for Future Preclinic Studies in Regenerative Medicine. Circ Res. 2019; 124 (6): 938-951. |
| [35] | ORYAN A, ALIDADI S, MOSHIRI A, e al. Platelet-rich plasma for bone healing and regeneration. Expert Opin Biol Ther. 2016; 16 (2): 213-232. HOLTHAUS MG, STOLLE J, TRECCANI L, et al. Orientation of humanosteoblasts on hydroxyapatite-based microchannels. Acta Biomater. 2012; 8 (1): 394-403 WEINER S, WAGNER D. The Material Bone: Structure-Mechanical Function Relations. Annu Rev Mater Res. 2003; 28: 271-298. WANG XJ, LOU T, ZHAO WH, et al. The effect of fiber size and pore size on cell proliferation and infiltration in PLLA scaffolds on bone tissue engineering. J Biomater Appl. 2016; 30 (10): 1545-1551. |
| [36] | HOLTHAUS MG, STOLLE J, TRECCANI L, et al. Orientation of humanosteoblasts on hydroxyapatite-based microchannels. Acta Biomater. 2012; 8 (1): 394-403. |
| [37] | WEINER S, WAGNER D. The Material Bone: Structure-Mechanical Function Relations. Annu Rev Mater Res. 2003; 28: 271-298. |
| [38] | WANG XJ, LOU T, ZHAO WH, et al. The effect of fiber size and pore size on cell proliferation and infiltration in PLLA scaffolds on bone tissue engineering. J Biomater Appl. 2016; 30 (10): 1545-1551. |
| [39] | WON JE, LEE YS, PARK JH, et al. Hierarchical microchanneled scaffolds modulate multiple tissue-regenerative processes of immune responses, angiogenesis, and stem cell homing. Biomaterials. 2020; 227: 119548. |
| [40] | PAN HH, XIE YT, ZHANG ZQ, et al. Immunomodulation effect of a hierarchical macropore/nano surface on osteogenesis and angiogenesis. Biomed Mater. 2017; 12 (4): 045006. |
| [41] | Chen Li, Wang Wu, Application and progress of surface modification in neuro-interventional therapy materials [J], Journal of Interventional Radiology, July 2020, Vol. 29, Issue 7. |
| [42] | Guo Jingtao, Ma Changsheng, Zhang Shuliang, et al. Application of drug elution in coronary multiple stents, China Medicine, June 2007, Vol. 2, No. 6. |
| [43] | Zhu Y, Zhang H, Zhang Y, et al. Endovascular metal devices for the treatment of cerebrovascular diseases [J]. Adv Mater, 2019, 31: e1805452. |
| [44] | X. Sun, Z. Pang, H. Ye, B. Qiu, L. Guo, J. Li, J. Ren, Y. Qian, Q. Zhang, J. Chen, X. Jiang. Co-delivery of pEGFP-hTRAIL and paclitaxel to brain glioma mediated by an angiopep-conjugated liposome [J]. Biomaterials. 2012, (33): 916-924. |
| [45] | W. Zhang, Y. Shi, Y. Chen, J. Ye, X. Sha, X. Fang. Multifunctional Pluronic P123/F127 mixed polymeric micelles loaded with paclitaxel for the treatment of multidrug resistant tumors [J]. Biomaterials. 2011, (32): 2894-2906. |
| [46] | J. Yang, Y. Zeng, C. Zhang, Y. Chen, Z. Yang, Y. Li, X. Leng, D. Kong, X. Wei, H. Sun, C. Song. The prevention of restenosis in vivo with a VEGF gene and paclitaxel co-eluting stent [J]. Biomaterials. 2013, (34): 1635-1643. |
| [47] | C. K. S. Pillai, W. Paul, C. P. Sharma. Chitin and chitosan polymers: Chemistry, solubility and fiber formation [J]. Progress in Polymer Science. 2009, (34): 641-678. |
| [48] | J. Grant, H. Lee, R. C. W. Liu, C. Allen. Intermolecular Interactions and Morphology of Aqueous Polymer/Surfactant Mixtures Containing Cationic Chitosan and Nonionic Sorbitan Esters [J]. Biomacromolecules. 2008, (9): 2146-2152. |
| [49] | P. Kandra, H. P. J. Kalangi. Current understanding of synergistic interplay of chitosan nano particles and anticancer drugs: merits and challenges [J]. Applied Microbiology and Biotechnology. 2015, (99): 2055-2064. |
| [50] | Tang Jing, Preparation of paclitaxel/chitosan co-assembled nanofibers and their application in drug-eluting stents [J]. |
| [51] | Zhang Zhiping, Ge Hua, Anti-vascular smooth muscle proliferation and migration drug coating and restenosis after stent placement [J], Chinese Tissue Engineering Research, Vol. 16, No. 12, March 2012. |
| [52] | Venkatraman S. Boey F Release profiles in drug-elut}ng stents: iseuesand uncartaintjes. J Control Release. 2007; 120 (3): 149-160. |
| [53] | Wang X, Venkatraman SS, Boey FY, et al. Controlled release of sirolimus from a multilayered PLGA stent matrix. Biomaterials•2006: 27 (32): 5588-5595. |
| [54] | Li Qiyun, Chen Zhong, Gu Xingzhong, A novel polymer carrying rapamycin-eluting vascular stent to inhibit intimal hyperplasia [J], Chinese Tissue Engineering Research and Clinical Rehabilitation, January 2009, Vol. 73, No. 4. |
| [55] | Sun Yuanke, Process research on preparation of vascular stent nanoparticle drug-carrying coating based on electrophoretic deposition method [J]. |
| [56] | Xu Pengqi, Preparation of mitochondrial-targeted Fe3O4 nanoparticles and evaluation of its in vitro magnetocaloric efficacy [J]. |
APA Style
Wenqi Fan. (2021). Application and Manufacturing Method of Stent Material in Vascular Regeneration and Prevention of Vascular Restenosis. International Journal of Materials Science and Applications, 10(2), 35-45. https://doi.org/10.11648/j.ijmsa.20211002.13
ACS Style
Wenqi Fan. Application and Manufacturing Method of Stent Material in Vascular Regeneration and Prevention of Vascular Restenosis. Int. J. Mater. Sci. Appl. 2021, 10(2), 35-45. doi: 10.11648/j.ijmsa.20211002.13
AMA Style
Wenqi Fan. Application and Manufacturing Method of Stent Material in Vascular Regeneration and Prevention of Vascular Restenosis. Int J Mater Sci Appl. 2021;10(2):35-45. doi: 10.11648/j.ijmsa.20211002.13
Share This Article
Twitter
Linked In
Facebook
Copy
Download@article{10.11648/j.ijmsa.20211002.13,
author = {Wenqi Fan},
title = {Application and Manufacturing Method of Stent Material in Vascular Regeneration and Prevention of Vascular Restenosis},
journal = {International Journal of Materials Science and Applications},
volume = {10},
number = {2},
pages = {35-45},
doi = {10.11648/j.ijmsa.20211002.13},
url = {https://doi.org/10.11648/j.ijmsa.20211002.13},
eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijmsa.20211002.13},
abstract = {With the development of biological tissue engineering, vascular stent materials have been greatly improved. Synthetic polyester polymers and bio-derived materials with excellent biocompatibility, biodegradability and mechanical strength have greatly improved. These are ideal tissue vascular scaffold materials. Vascular stents mainly play two roles in the body: vascular regeneration and prevention of vascular restenosis. In terms of vascular regeneration, the repair of common bone defects and the pulp regeneration require revascularization. This type of stent has production-promoting ability of adopting the multi-level microtubule structure. Different aperture induces different vascular behavior of making the adhered macrophages deforming correspondingly, promoting the infiltration of endothelial cells into the extracellular matrix and accelerating the formation of new blood vessels. In the treatment of atherosclerosis, stents can not only support blood vessels, but also prevent blood vessel from restenosis and keep blood vessels opening for a long time. To this aim, stents generally carry and controllable release of drugs of inhibiting the proliferation of smooth muscle cells. Such stents are called drug-eluting stents. Usual drugs are rapamycin and paclitaxel. This review intends to mix the nano-scale anticancer drug nanoenzymes with polymers on the surface of the stent and exert the sustained drug releasing function of the drug-eluting stent. This type of drug-eluting stent can not only prevent blood vessel restenosis, but also treat cancer by attacking tumor cells.},
year = {2021}
}
TY - JOUR T1 - Application and Manufacturing Method of Stent Material in Vascular Regeneration and Prevention of Vascular Restenosis AU - Wenqi Fan Y1 - 2021/04/23 PY - 2021 N1 - https://doi.org/10.11648/j.ijmsa.20211002.13 DO - 10.11648/j.ijmsa.20211002.13 T2 - International Journal of Materials Science and Applications JF - International Journal of Materials Science and Applications JO - International Journal of Materials Science and Applications SP - 35 EP - 45 PB - Science Publishing Group SN - 2327-2643 UR - https://doi.org/10.11648/j.ijmsa.20211002.13 AB - With the development of biological tissue engineering, vascular stent materials have been greatly improved. Synthetic polyester polymers and bio-derived materials with excellent biocompatibility, biodegradability and mechanical strength have greatly improved. These are ideal tissue vascular scaffold materials. Vascular stents mainly play two roles in the body: vascular regeneration and prevention of vascular restenosis. In terms of vascular regeneration, the repair of common bone defects and the pulp regeneration require revascularization. This type of stent has production-promoting ability of adopting the multi-level microtubule structure. Different aperture induces different vascular behavior of making the adhered macrophages deforming correspondingly, promoting the infiltration of endothelial cells into the extracellular matrix and accelerating the formation of new blood vessels. In the treatment of atherosclerosis, stents can not only support blood vessels, but also prevent blood vessel from restenosis and keep blood vessels opening for a long time. To this aim, stents generally carry and controllable release of drugs of inhibiting the proliferation of smooth muscle cells. Such stents are called drug-eluting stents. Usual drugs are rapamycin and paclitaxel. This review intends to mix the nano-scale anticancer drug nanoenzymes with polymers on the surface of the stent and exert the sustained drug releasing function of the drug-eluting stent. This type of drug-eluting stent can not only prevent blood vessel restenosis, but also treat cancer by attacking tumor cells. VL - 10 IS - 2 ER -
Information
Email: